1. Roche Earnings Preview: Oncology Drugs And Tamiflu Will Help The Revenue Growth http://www.trefis.com/stock/rhhby/articles/275728/roche-earnings-preview-oncology-drugs-and-tamiflu-will-help-the-revenue-growthearnings-on-28-jan/2015-01-26 by Trefis Team $RHHBY $JNJ $MRK

  2. Bristol-Myers Squibb Earnings Preview: Increasing Sales From New Drugs May Ease Th... http://www.trefis.com/stock/bmy/articles/275448/bristol-myers-squibb-earnings-preview-increasing-sales-from-new-drugs-may-ease-the-pressure-off-revenue-growth-earnings-on-27-jan/2015-01-23 by Trefis Team $BMY $MRK $RHHBY

  3. How Roche Will Perform In 2015? http://www.trefis.com/stock/rhhby/articles/273912/how-roche-will-perform-in-2015/2015-01-09 by Trefis Team $RHHBY $JNJ $PFE

  4. What 2015 Will Bring For Bristol-Myers Squibb http://www.trefis.com/stock/bmy/articles/273537/what-2015-will-bring-for-bristol-myers-squibb/2015-01-07 by Trefis Team $BMY $MRK $RHHBY

  5. The Year 2014 In Review: How Johnson & Johnson Became More Pharma Focused http://www.trefis.com/stock/jnj/articles/271038/the-year-2014-in-review-how-johnson-johnson-became-more-pharma-focused/2014-12-29 by Trefis Team $JNJ $RHHBY $PFE

  6. Weekly Pharmaceutical Notes: Pfizer, Bristol-Myers Squibb And Roche http://www.trefis.com/stock/mrk/articles/272438/weekly-pharmaceutical-notes-pfizer-bristol-myers-squibb-and-roche/2014-12-26 by Trefis Team $RHHBY $PFE $MRK

  7. Roche s Double Drug Failure Is Meaningful http://www.trefis.com/stock/rhhby/articles/272136/roches-double-drug-failure-is-meaningful/2014-12-24 by Trefis Team $RHHBY $BMY $MRK

  8. Roche Hopes For Melanoma Therapy Approval http://www.trefis.com/stock/rhhby/articles/269983/roche-hopes-for-melanoma-therapy-approval/2014-12-17 by Trefis Team $RHHBY $MRK $BMY

  9. Brinson Patrick s Christopher S. James: All Catalysts Are Not Created Equal http://www.trefis.com/stock/rgls/articles/268638/brinson-patricks-christopher-s-james-all-catalysts-are-not-created-equal/2014-12-08 $RGLS $RHHBY

  10. Roche s Expands Diagnostics Position With The Acquisition Of Ariosa http://www.trefis.com/stock/rhhby/articles/268459/roches-expands-diagnostics-position-with-the-acquisition-of-ariosa/2014-12-04 by Trefis Team $RHHBY $BSX $JNJ

  11. Weekly Pharmaceutical Notes: Pfizer, Johnson & Johnson, Bristol-Myers Squibb And Roche http://www.trefis.com/stock/pfe/articles/266661/weekly-pharmaceutical-notes-pfizer-johnson-johnson-bristol-myers-squibb-and-roche/2014-11-21 by Trefis Team $PFE $JNJ $BMY

  12. Roche s Avastin Gets Approval For Ovarian Cancer, But Incremental Revenues Will Be... http://www.trefis.com/stock/rhhby/articles/266345/roches-avastin-gets-approval-for-ovarian-cancer-but-incremental-revenues-will-be-small/2014-11-20 by Trefis Team $RHHBY $BMY $MRK

  13. Weekly Pharmaceuticals Notes: Pfizer, Bristol-Myers, Squibb, Merck And Roche http://www.trefis.com/stock/mrk/articles/264497/weekly-pharmaceuticals-notes-pfizer-bristol-myers-squibb-merck-and-roche/2014-11-10 by Trefis Team $MRK $RHHBY $BMY

  14. Roche To Invest In Diagnostics Manufacturing Unit In China http://www.trefis.com/stock/rhhby/articles/264345/roche-to-invest-in-diagnostics-manufacturing-unit-in-china/2014-11-07 by Trefis Team $RHHBY $JNJ $BSX

  15. Pfizer Earnings Were Not Impressive http://www.trefis.com/stock/pfe/articles/262515/pfizer-earnings-were-not-impressive/2014-10-29 by Trefis Team $PFE $MRK $RHHBY

  16. Bristol-Myers Squibb Rises On Earnings Boost http://www.trefis.com/stock/bmy/articles/261967/bristol-myers-squibb-rises-on-earnings-boost/2014-10-27 by Trefis Team $BMY $MRK $RHHBY

  17. Bristol-Myers Squibb Earnings Preview: What We Are Watching http://www.trefis.com/stock/bmy/articles/261289/bristol-myers-squibb-earnings-preview-what-we-are-watching-24-oct/2014-10-22 by Trefis Team $BMY $MRK $RHHBY

  18. Roche s Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term http://www.trefis.com/stock/rhhby/articles/259867/roches-cancer-drug-sales-continue-to-grow-may-face-competition-in-medium-term/2014-10-21 by Trefis Team $RHHBY $PFE $MRK

  19. Weekly Pharma Notes: Pfizer, Bristol-Myers Squibb, Johnson & Johnson, Merck And Roche http://www.trefis.com/stock/pfe/articles/259484/weekly-pharma-notes-pfizer-bristol-myers-squibb-johnson-johnson-merck-and-roche/2014-10-13 by Trefis Team $BMY $JNJ $MRK

  20. Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab http://www.trefis.com/stock/bmy/articles/258364/bristol-myers-squibb-getting-close-to-lung-cancer-approval-for-nivolumab/2014-10-02 by Trefis Team $BMY $MRK $RHHBY

  21. What Is InterMune s Revenue Potential For Roche? http://y.ahoo.it/N5da9H9A by Trefis Team $RHHBY $JNJ $PFE

  22. Weekly Pharma Notes: Bristol-Myers Squibb, Johnson & Johnson, Merck And Roche http://y.ahoo.it/OnViRGME by Trefis Team $BMY $JNJ $MRK

  23. Weekly Pharma Notes: Bristol-Myers Squibb, Pfizer, Merck And Roche http://y.ahoo.it/GKX45bDf by Trefis Team $BMY $MRK $PFE

  24. Roche s Sales Inch Up Slowly And Steadily http://y.ahoo.it/JeophcLo by Trefis Team $RHHBY

  25. Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth ... http://y.ahoo.it/BxoAlyLY by Trefis Team $RHHBY $PFE $MRK